๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancer

โœ Scribed by Katsuhiro Inoue; Makoto Ogawa; Jiro Inagaki; Noboru Horikoshi; Hiroaki Miyamoto; Koichi Ikeda; Noriko Usul; Hiroshi Nakada; Koichi Adachi

Publisher
Springer
Year
1984
Tongue
English
Weight
425 KB
Volume
13
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A randomized multicenter trial of cyclop
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer
โœ John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charl ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 388 KB

As of August 1984, 115 women with advanced breast cancer have been randomized to receive a combination of either cyclophosphamide, Novantrone (mitoxantrone) and 5-fluorouracil (CNF) or cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF). Seventy-one percent of all patients were post-

Treatment of advanced ovarian cancer: A
Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4โ€ฒepi-adriamycin in combination with cisplatin and cyclophosphamide
โœ Bezwoda, W. R. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'